The global Scopolamine market is estimated to be valued at US$ 462.7 million in 2022 and is expected to exhibit a CAGR of 4.8% over the forecast period, as highlighted in a new report published by Coherent Market Insights.
A) Market Overview:
Scopolamine is a medication used to prevent nausea and vomiting caused by motion sickness or post-operative conditions. It works by blocking certain natural substances in the body that cause nausea and vomiting. The ... Read more
